Missouri Business Headlines

Biosimilars bill, signed by the governor, makes good business sense

Posted on

On June 8, Gov. Jay Nixon signed Senate Bill 875, legislation intended to modernize Missouri law to allow safe substitutions for biologic medicines.

“We believe a coherent policy outlining the parameters and process for safe substitution of interchangeable biologics for all health care stakeholders – prescribers, pharmacists, payers and manufacturers – will ensure patients have access to high quality, safe and effective medicines,” said Dan Mehan, Missouri Chamber president and CEO. “Missouri is taking the lead in both the research and manufacture of biologics and biosimilars by ensuring state laws are consistent and aligned with other pro-business states.”

Gov. Nixon’s action is good news for pharmaceutical manufacturers, but most important, it is a valuable step toward controlling drug costs for consumers.

“It means significant savings for Missouri employers, since a large portion of health care coverage costs are shouldered by employers who provide health benefits for employees,” Mehan said.

Senate Bill 875 was sponsored by Sen. Kurt Schaefer, a Republican from Columbia. The bill was handled in the House by Rep. Tila Hubrecht, a Republican from Dexter.

« Back to News